Abstract:Background and aim: Human immunodeficiency virus (HIV) remains a significant global health challenge, with approximately 39 million people living with HIV worldwide as of 2022. Despite progress in antiretroviral therapy, achieving the UNAIDS "95-95-95" target to end the HIV epidemic by 2025 faces challenges, particularly in sub-Saharan Africa. The pursuit of an HIV vaccine is crucial, offering durable immunity and the potential to end the epidemic. Challenges in vaccine development include the lack of known immune correlates, suitable animal models, and HIV's high mutation rate. This study aims to explore the current state of HIV vaccine development, focusing on the challenges and innovative approaches being investigated. Methods: In writing this review, we conducted a search of medical databases such as PubMed, ResearchGate, Web of Science, Google Scholar, and Scopus. The exploration of messenger ribonucleic acid vaccines, which have proven successful in the SARS-CoV-2 pandemic, presents a promising avenue for HIV vaccine development. Understanding HIV-1's ability to infiltrate various bodily compartments, establish reservoirs, and manipulate immune responses is critical. Robust cytotoxic T lymphocytes and broadly neutralizing antibodies are identified as key components, though their production faces challenges. Innovative approaches, including computational learning and advanced drug delivery systems, are being investigated to effectively activate the immune system. Results and conclusions: Discrepancies between animal models and human responses have hindered the progress of vaccine development. Despite these challenges, ongoing research is focused on overcoming these obstacles through advanced methodologies and technologies. Addressing the challenges in HIV vaccine development is paramount to realizing an effective HIV-1 vaccine and achieving the goal of ending the epidemic. The integration of innovative approaches and a deeper understanding of HIV-1's mechanisms are essential steps toward this transformative breakthrough.

Toward Functional Eradication of HIV Infection

Recent progress on functional cure for acquired immunodeficiency syndrome

Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs

Translational eradication approaches

Gene therapy for HIV infection

Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021

HIV-1 Remission: Accelerating the Path to Permanent HIV-1 Silencing

Latency reversal and viral clearance to cure HIV-1

Advanced Therapies for Human Immunodeficiency Virus

HIV-1 functional cure: will the dream come true?

Immune targeting of HIV-1 reservoir cells: a path to elimination strategies and cure

Antibody-based Candidate Therapeutics Against HIV-1: Implications for Virus Eradication and Vaccine Design

Editing out HIV: application of gene editing technology to achieve functional cure

HIV Pol: does it offer therapeutic targets for HIV?

HIV and the Macrophage: From Cell Reservoirs to Drug Delivery to Viral Eradication

HIV Vaccines and Cure

Advancements in Developing Strategies for Sterilizing and Functional HIV Cures

Current progress and challenges in HIV gene therapy

Treatment of Human Immunodeficiency Virus-1: Current Challenges and Future Perspectives

Interventions during Early Infection: Opening a Window for an HIV Cure?

HIV vaccination: Navigating the path to a transformative breakthrough-A review of current evidence